# Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

> **NCT00198263** · PHASE4 · COMPLETED · sponsor: **Inovio Pharmaceuticals** · enrollment: 95 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **COMBINATION_PRODUCT:** Medpulser Electroporation with Bleomycin

## Key facts

- **NCT ID:** NCT00198263
- **Lead sponsor:** Inovio Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198263, "Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00198263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*